ONCOLOGY

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors Article

A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk Prediction and Clinical Care Review

A Novel Method for Evaluating Early Tumor Response Based on Daily CBCT Images for Lung SBRT Article

A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF HEDGEHOG (HH) PATHWAY INHIBITOR GDC-0449 AS MAINTENANCE THERAPY IN PATIENTS WITH OVARIAN CANCER IN 2(ND) OR 3(RD) COMPLETE REMISSION (CR) Meeting Abstract

A Phase (Ph) III clinical program: 1L atezolizumab (atezo) plus chemotherapy (chemo) in chemo-naive advanced NSCLC Meeting Abstract

A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer Article

A Phase I Dose-Escalation Study of Tivantinib (ARQ 197) in Adult Patients with Metastatic Solid Tumors Article

A Phase I Study of Sunitinib plus Bevacizumab in Advanced Solid Tumors Article

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors Article

A Phase I Trial of Trametinib in Combination with Sorafenib in Patients with Advanced Hepatocellular Cancer Article

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only Article

A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers Article

A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission Article

A Phase Ib, Open-Label Study of Dalantercept, an Activin Receptor-Like Kinase 1 Ligand Trap, plus Sorafenib in Advanced Hepatocellular Carcinoma Article

A PhaseII,Single-Arm,Open-Label, Bayesian Adaptive Efficacy and Safety Study ofPBI-05204 in Patients with StageIVMetastatic Pancreatic Adenocarcinoma Article

A Qualitative Study of Decision-making (DM) in Surgery and Cancer Care: an Indian Perspective Article

A Randomized Phase II Study of Carboplatin With Weekly or Every-3-Week Nanoparticle Albumin-Bound Paclitaxel (Abraxane) in Patients With Extensive-Stage Small Cell Lung Cancer Article

A Randomized, Double-Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX-427) in Patients with Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer: The SPRUCE Trial Article

A bioequivalence study of proposed bevacizumab biosimilar, MYL-1402O (A) vs EU-Avastin (B) and US-Avasting (C) Meeting Abstract

A comparative clinical study of PF-06439535, a candidate bevacizumab biosimilar, and reference bevacizumab, in patients with advanced non-squamous non-small cell lung cancer. Meeting Abstract

A comparison of combination docetaxel/carboplatin versus sequential docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Meeting Abstract

A comparison of patient outcomes in advanced ovarian cancer: Assay-informed vs. empirically treated Meeting Abstract

A first-in-human (FIH), phase 1/2, dose-escalation, dose-optimization, and dose-expansion study of PARP1-selective inhibitor IMP1734 in participants with advanced solid tumors. Meeting Abstract

A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials Article

A live cell microfluidics device utilizing phenotypic biomarkers for prostate cancer. Meeting Abstract

A method to integrate an institutional database with multiple practice EHRs. Meeting Abstract

A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer Article

A national analysis evaluating the role of neoadjuvant chemoradiotherapy in upper esophageal cancer Meeting Abstract

A non-invasive urine exosome gene expression assay (ExoIntelliScore Prostate) to predict pathologic stage and grade in the prostatectomy specimen. Meeting Abstract

A novel drug to treat advanced melanoma. Meeting Abstract

A novel live cell platform diagnostic utilizing phenotypic biomarkers for assessing prostate cancer aggressiveness. Meeting Abstract

A novel therapeutic compound, tolfenamic acid, inhibits ovarian cancer cell growth: Therapeutic implications Meeting Abstract

A pharmacokinetics study of proposed bevacizumab biosimilar MYL-1402O vs EU-bevacizumab and US-bevacizumab Article

A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer Article

A phase 1b/2 dose escalation and expansion study of OP-1250 in combination with ribociclib or alpelisib in patients with advanced and/or metastatic estrogen receptor-positive (ER+)/HER2-negative (HER2-) breast cancer Meeting Abstract

A phase 2 study (DisTinGuish) of DKN-01 in combination with tislelizumab plus chemotherapy as first-line (1L) therapy in patients with advanced gastric or GEJ adenocarcinoma (GEA) Meeting Abstract

A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) Meeting Abstract

A phase 2 study of intratumoral tavokinogene telseplasmid (tavo) plus electroporation with pembrolizumab in patients with inoperable locally advanced or metastatic triple negative breast cancer Meeting Abstract

A phase 2 study of poziotinib in patients with EGFR or HER2 exon 20 mutation-positive non-small cell lung cancer Meeting Abstract

A phase 2/3 randomized study of CTX-009 combination in 2L biliary tract cancer: COMPANION-002. Meeting Abstract

A phase 3b safety study of fixed-dose durvalumab plus tremelimumab or durvalumab monotherapy in advanced solid malignancies (STRONG): Urothelial and non-urothelial urinary tract carcinoma module A. Meeting Abstract

A phase I dose escalation study of eryaspase in combination with modified FOLFIRINOX in locally advanced and metastatic pancreatic ductal adenocarcinoma. Meeting Abstract

A phase I pharmacokinetic and pharmacodynamic study of S-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors Article

A phase I study to evaluate next-generation DNA sequencing testing in rectal swabs prior to transrectal prostate biopsy for cancer screening and diagnosis. Meeting Abstract

A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations Article

A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with carboplatin and etoposide in extensive stage small cell lung cancer Article

A phase I trial investigating apoptosis induction with tumor necrosis factor or radiation alone prior to intratumoral injection of autologous dendritic cells in patients with locally advanced or low volume metastatic pancreatic cancer. Meeting Abstract

A phase I trial of vorinostat in combination with bevacizumab and irinotecan in recurrent glioblastoma Meeting Abstract

A phase I/II open-label, first-in-human, multicenter, dose escalation and dose expansion study of OP-1250 monotherapy in adult subjects with advanced and/or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer Meeting Abstract

A phase II (ph2), randomized study of magrolimab with bevacizumab and FOLFIRI in previously treated patients with advanced inoperable metastatic colorectal cancer (mCRC) Meeting Abstract

A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer Meeting Abstract

A phase II study of the combination of BKM120 (buparlisib) and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM). Meeting Abstract

A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer Meeting Abstract

A phase II, open-label, multicenter study of the ALK inhibitor alectinib in an ALK plus non-small-cell lung cancer (NSCLC) US/Canadian population who had progressed on crizotinib (NP28761). Meeting Abstract

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer (vol 26, pg 1923, 2015) Correction

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer(aEuro) Article

A phase III trial-in-progress called REPLATINUM that compares RRx-001+a platinum doublet to a platinum doublet in third-line or beyond small cell lung cancer. Meeting Abstract

A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel plus sorafenib in women with node positive or high-risk breast cancer. Meeting Abstract

A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer Article

A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer Article

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC) Article

A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of farletuzumab (MORAb-003) in combination with weekly paclitaxel in subjects with platinum-resistant or refractory relapsed ovarian cancer Meeting Abstract

A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC) Article

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer Article

A retrospective safety and efficacy analysis of combination therapy using Gliadel wafers plus external beam radiation therapy with concurrent temozolomide in newly diagnosed glioblastoma multiforme patients Meeting Abstract

A review of management strategies of malignant gliomas in the elderly population Review

AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo Article

ACR Appropriateness Criteria (R) Adjuvant Management of Early-Stage Endometrial Cancer Article

ACR Appropriateness Criteria (R) Adjuvant Therapy in Vulvar Cancer Article

ACR Appropriateness Criteria (R) Management of Recurrent Endometrial Cancer Article

ACTA ONCOLOGICA Journal

ALK-Targeted Therapy in NSCLC: Likely to Be of Benefit but Not Quite Ready for Prime Time THE HUSAIN/RUDIN ARTICLE REVIEWED Editorial Material

AMBASSADOR Alliance A031501: Phase III randomized adjuvant study of pembrolizumab in muscle-invasive and locally advanced urothelial carcinoma (MIUC) vs observation. Meeting Abstract

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS Journal

ANNALS OF ONCOLOGY Journal

ANNALS OF SURGICAL ONCOLOGY Journal

ANNALS OF TRANSLATIONAL MEDICINE Journal

ANTICANCER RESEARCH Journal

ARIEL3: A phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) Meeting Abstract

ARIEL3: A phase 3, randomized, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian cancer (OC). Meeting Abstract

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO-The MIMOSA Study Article

Absence of interaction of cabazitaxel on the pharmacokinetics of midazolam: Results of a drug-drug interaction study in patients with advanced solid tumors Meeting Abstract

Accelerated Partial Breast Irradiation: Potential Roles Following Breast-Conserving Surgery Article

Accuracy of endoscopic ultrasound staging for T2N0 esophageal cancer: a National Cancer Database analysis Article

Acidity Generated by the Tumor Microenvironment Drives Local Invasion Article

Acquired EGFR-resistant mutations in non-small cell lung cancer (NSCLC). Meeting Abstract

Activity and Safety of Mobocertinib (TAK-788) in Previously Treated Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations from a Phase I/II Trial Article

Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement Meeting Abstract

Acute Coronary Syndrome Management in Cancer Patients Review

Adenocarcinoma of Colon Presenting As Cushing's Syndrome Editorial Material

Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience Article

Adjuvant Radiation Therapy Increases Overall Survival in Node-Positive Gastric Cancer Patients With Aggressive Surgical Resection and Lymph Node Dissection A SEER Database Analysis Article

Adjuvant Radiotherapy and Lymph Node Status for Pancreatic Cancer Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data Article

Adjuvant Whole-Brain Radiotherapy Versus Observation after Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study Editorial Material

Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy Article

AdvanTIG-302: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus tislelizumab (TIS) versus pembrolizumab (PEM) in programmed death ligand-1 (PD-L1) selected, previously untreated, locally advanced, unresectable or metastatic non-small cell lung cancer (NSCLC). Meeting Abstract

Advanced colorectal cancer is associated with impaired interleukin 12 and enhanced interleukin 10 production Article

Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction Editorial Material

Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy Letter

Adverse changes in body composition of cancer surivors with BRCA mutations. Meeting Abstract

Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol Editorial Material

Afatinib in combination with pembrolizumab in patients (pts) with stage IIIB/IV squamous cell carcinoma (SCC) of the lung Meeting Abstract

Aggressive primary malignant myoepithelioma of the maxillary sinus Letter

Alcohol consumption and risk of urothelial cell bladder cancer in the European prospective investigation into cancer and nutrition cohort Article

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial Article

Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study Article

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations. Meeting Abstract

Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study Article

Altered Fractionation Schedules in Radiation Treatment: A Review Review

Alternative Strategy to Achieve Increased Overall Survival and Better Quality of Life in Patients With Second-Line Advanced Non-Small-Cell Lung Cancer Letter

Amrubicin and carboplatin with pegfilgrastim in patients with extensive-stage small-cell lung cancer (ES-SCLC): A phase II study of the Sarah Cannon Research Institute (SCRI). Meeting Abstract

An Antibody-Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors Article

An Overview of Endometrial Cancer with Novel Therapeutic Strategies Review

An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer Article

Anal Cancer: Current Standards in Care and Recent Changes in Practice Review

Anastomotic leak and neoadjuvant chemoradiotherapy in esophageal cancer Article

Anti-epidermal growth factor (EGFR) antibody, cetuximab, in patients with stage IV colorectal carcinoma who failed all standard therapy: Final report of an access protocol. Meeting Abstract

Antibodies to the epidermal growth factor receptor in non-small cell lung cancer: Current status of matuzumab and panitumumab Article

Antitumor activity of ginsenoside Rg3 in melanoma through downregulation of the ERK and Akt pathways Article

Application of artificial intelligence (AI) features of nuclear morphology from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy. Meeting Abstract

Applications of Cardiac Computed Tomography in the Cardio-Oncology Population Review

Assay Development for detection of estrogen responsive gene histone acetylation in breast cancer circulating tumor cells Meeting Abstract

Assessing Response to Treatment in Non-Small-Cell Lung Cancer: Role of Tumor Volume Evaluated By Computed Tomography Article

Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry Article

Association between adjuvant radiation treatment and breast cancer-specific mortality among older women with comorbidity burden: A comparative effectiveness analysis of SEER-MHOS Article

Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy Article

Association between progression-free survival (PFS) rate (PFSR) and overall survival (OS) in LUME-Meso, a study of nintedanib (N) vs. placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in patients (pts) with malignant pleural mesothelioma (MPM). Meeting Abstract

Association betweenBRCA1 and BRCA2 mutations and prognosis in women with endometrial carcinoma. Meeting Abstract

Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk Article

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials Article

Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation Article

Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC. Meeting Abstract

Association of ephrinB2 (B2) expression on overall survival (OS) and resistance to PD1/L1 inhibitors (inh) in metastatic urothelial carcinoma (mUC) Meeting Abstract

Association of peripheral blood neutrophil-lymphocyte ratio (NLR) and red cell distribution width (RDW) with immune checkpoint inhibitors (ICIs) for metastatic urothelial carcinoma (mUC). Meeting Abstract

Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma Article

Association of the presence of estrogen and progesterone receptors in uterine carcinosarcoma with improved survival and increased immunogenicity. Meeting Abstract

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial Article

Atezolizumab in first-line treatment of metastatic nonsquamous non-small cell lung cancer in the real-world setting. Meeting Abstract

Atypical meningioma: Randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy Article

Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: A prognostic factor analysis Article

Avelumab first-line maintenance therapy for locally advanced/metastatic urothelial carcinoma: Results from the real-world US PATRIOT-II study. Meeting Abstract

B-F1RST: Assessment of novel blood-based biomarkers in patients with first-line advanced or metastatic NSCLC receiving atezolizumab monotherapy Meeting Abstract

BMC CANCER Journal

BONE MARROW TRANSPLANTATION Journal

BRACHYTHERAPY Journal

BRAF mutation is not predictive of long-term outcome in papillary thyroid carcinoma Article

BREAST CANCER RESEARCH AND TREATMENT Journal

BREAST JOURNAL Journal

BRITISH JOURNAL OF CANCER Journal

Baseline Quality of Life Factors Predict Long Term Survival after Elective Resection for Colorectal Cancer Article

Bemarituzumab with modified FOLFOX6 for advanced FGFR2-positive gastroesophageal cancer: FIGHT Phase III study design Article

Best Practices in Treatment Selection for Patients With Advanced NSCLC Article

Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET) Meeting Abstract

Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer Article

Biomarker and Tumor Responses of Oral Cavity Squamous Cell Carcinoma to Trametinib: A Phase II Neoadjuvant Window-of-Opportunity Clinical Trial Article

Bladder Cancer Review

Blood Serum From Head and Neck Squamous Cell Carcinoma Patients Induces Altered MicroRNA and Target Gene Expression Profile in Treated Cells Article

Blood first line ready screening trial ( B-F1RST) and blood first assay screening trial (BFAST) enable clinical development of novel blood-based biomarker assays for tumor mutational burden (TMB) and somatic mutations in 1L advanced or metastatic Meeting Abstract

Blood transfusions and recurrence in head and neck cancer. Letter

Breast Preservation in Women With Giant Juvenile Fibroadenoma Article

Breast Reconstruction and Radiation Therapy Review

Bromodomain inhibitor JQ1 inhibits cholangiocarcinoma tumor growth in patient-derived xenograft models Meeting Abstract

CANCER Journal

CANCER BIOLOGY & THERAPY Journal

CANCER CHEMOTHERAPY AND PHARMACOLOGY Journal

CANCER CONTROL Journal

CANCER GENETICS Journal

CANCER IMMUNOLOGY IMMUNOTHERAPY Journal

CANCER INVESTIGATION Journal

CANCER JOURNAL Journal

CANCER LETTERS Journal

CANCER MANAGEMENT AND RESEARCH Journal

CANCER MEDICINE Journal

CANCER NURSING Journal

CANCER PREVENTION RESEARCH Journal

CANCER RESEARCH Journal

CANCER RESEARCH AND TREATMENT Journal

CARDIAC SYNOVIAL SARCOMA WITH TRANSLOCATION (X 18) ASSOCIATED WITH ASBESTOS EXPOSURE Article

CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells Article

CLINICAL & EXPERIMENTAL METASTASIS Journal

CLINICAL & TRANSLATIONAL ONCOLOGY Journal

CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY Journal

CLINICAL BREAST CANCER Journal

CLINICAL CANCER RESEARCH Journal

CLINICAL JOURNAL OF ONCOLOGY NURSING Journal

CLINICAL LUNG CANCER Journal

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA Journal

CNS activity of poziotinib in NSCLC with exon 20 insertion mutations. Meeting Abstract

CRESTONE - Clinical study of response to seribantumab in tumors with neuregulin-1 (NRG1) Fusions - A phase 2 study of the anti-HER3 mAb for advanced or metastatic solid tumors (NCT04383210). Meeting Abstract

CRESTONE: Clinical study of response to seribantumab in tumors with neuregulin-1 (NRG1) fusions-A phase II study of the anti-HER3 mAb for advanced or metastatic solid tumors (NCT04383210). Meeting Abstract

CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy Review

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY Journal

CURRENT HEMATOLOGIC MALIGNANCY REPORTS Journal

CURRENT ONCOLOGY REPORTS Journal

CURRENT TREATMENT OPTIONS IN ONCOLOGY Journal

Cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma (PemCab). Meeting Abstract

Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature Review

Can pancreatic cancer behavior be predicted based on computed tomography measurements of fat and muscle mass? Article

Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: A preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium Article

Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: Report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium Article

Carcinomatous Meningitis in Non-Small-Cell Lung Cancer: Response to High-Dose Erlotinib Article

Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy Article

Caregiver-Oncologist Prognostic Concordance, Caregiver Mastery, and Caregiver Psychological Health and Quality of Life Article

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma? Article

Catumaxomab treatment of malignant ascites in patients with chemotherapy-refractory ovarian cancer: A phase II study Meeting Abstract

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial Article

Cediranib in combination with olaparib in patients without a germline BRCA1/2 mutation with recurrent platinum-resistant ovarian cancer: Phase IIb CONCERTO trial. Meeting Abstract

Cellular therapy in combination with cytokines improves survival in a xenograft mouse model of ovarian cancer Meeting Abstract

Central Nervous System Cancers Review

Central Nervous System Cancers Clinical Practice Guidelines in Oncology Review

Central Nervous System Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines Article

Central Nervous System Cancers, Version 2.2014 Featured Updates to the NCCN Guidelines Article

Central nervous system cancers. WoS Publication

Changes in serum soluble VEGFR-1 and Tie-2 receptors in colorectal cancer patients following surgical resections Article

Characterization and management of adverse events observed with mobocertinib (TAK-788) treatment for EGFR exon 20 insertion-positive non-small cell lung cancer Review

Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy Meeting Abstract

Characterization of KRAS Mutation Subtypes in Non-small Cell Lung Cancer Article

Characterization of KRAS mutations (mt) in non-small cell lung cancer (NSCLC). Meeting Abstract

Chemoradiation followed by adjuvant hysterectomy for the treatment of stage IB-2 cervical cancer: 10-year experience Meeting Abstract

Chemotherapeutic issues in the management of unresectable stage III non-small cell lung cancer Article

Chemotherapy, immunotherapy, or combination first-line treatment for metastatic urothelial carcinoma of the bladder: A large real-world experience. Meeting Abstract

Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx Article

Chronic thrombocytopenia in cancer patients: Impact on percutaneous coronary intervention and antiplatelet therapy. Meeting Abstract

Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population Article

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer Article

Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans Article

Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study. Meeting Abstract

Circulating tumor DNA (ctDNA) monitoring to inform maintenance outcomes in patients (pts) with advanced NSCLC treated with induction atezolizumab plus carboplatin plus nabpaclitaxel (A plus CnP) Meeting Abstract

Circulating tumor DNA (ctDNA) to predict response to neoadjuvant chemotherapy (NAC) and prognosis in patients (pts) with early breast cancer (BC). Meeting Abstract

Clinical Activity of Olvimulogene Nanivacirepvec-Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer The Nonrandomized Phase 2 VIRO-15 Clinical Trial Article

Clinical and immunologic effects of subcutaneously administered interleukin-12 and interferon alfa-2b: Phase I trial of patients with metastatic renal cell carcinoma or malignant melanoma Article

Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC). Meeting Abstract

Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer Article

Clinical predictors of prolonged clinical benefit (PCB) from pemetrexed (P) therapy in metastatic non-small cell lung cancer (mNSCLC) Meeting Abstract

Clinicopathologic Features and Outcomes of Patients With Lung Adenocarcinomas Harboring BRAF Mutations in the Lung Cancer Mutation Consortium Article

Clinicopathologic analysis of MMR gene mutations and uterine adenocarcinomas: An updated population-based study. Meeting Abstract

Clinicopathologic and molecular genetic comparison of primary uterine serous adenocarcinomas from African American and Caucasian women. Meeting Abstract

Codon 72 and Intron-3 polymorphisms in TP53 are risk factors for breast cancer Meeting Abstract

Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: Multicentre, prospective cohort study Article

Combinations of DNA Methyltransferase and Histone Deacetylase Inhibitors Induce DNA Damage in Small Cell Lung Cancer Cells: Correlation of Resistance with IFN-Stimulated Gene Expression Article

Combined modality therapy for stage III non-small cell lung cancer Article

Combined modality trials in unresectable stage III non-small cell lung cancer: The cancer and leukemia group B experience Article

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity Article

Combined use of MammaPrint and BluePrint assays to evaluate patients for response to neo-adjuvant chemotherapy for locally advanced breast cancer Meeting Abstract

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01. Meeting Abstract

Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation. Meeting Abstract

Comparison of Robotic-assisted versus Retropubic Radical Prostatectomy Performed by a Single Surgeon Article

Comparison of Unilateral Versus Bilateral Intensity-Modulated Radiotherapy for Surgically Treated Squamous Cell Carcinoma of the Palatine Tonsil Article

Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer Article

Considerations for second-line therapy of non-small cell lung cancer Article

Continued evaluation of a 31-gene expression profile test (GEP) for prediction of distant metastasis (DM) in cutaneous melanoma (CM) Meeting Abstract

Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer Article

Correlation of EGFR-expression with safety and efficacy outcomes in SQUIRE: a randomized, multicenter, open-label, phase III study of gemcitabine-cisplatin plus necitumumab versus gemcitabine-cisplatin alone in the first-line treatment of patients with stage IV squamous non-small-cell lung cancer Article

Correlation of safety and efficacy in atezolizumab therapy across indications Meeting Abstract

Correlation of tumor size and survival in pancreatic cancer Article

Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate pepinemab in combination with pembrolizumab for first-line treatment of patients with recurrent or metastatic head and neck cancer Meeting Abstract

Creation of Appropriate Use Criteria for Management of Uterine Clear Cell and Serous Carcinomas Meeting Abstract

Current Concepts in Penile Cancer Review

Current Status of Robot-Assisted Radical Prostatectomy: Progress Is Inevitable Editorial Material

Current and evolving treatment options for limited stage small cell lung cancer Review

Current approaches to advanced-stage non-small-cell lung cancer: First-line therapy in patients with a good functional status Article

Cystatin M: A novel candidate tumor suppressor gene for breast cancer Article

Cytotoxic T-cell immunity against telomerase reverse transcriptase in colorectal cancer patients Article

Cytotoxic chemotherapy in advanced non-small cell lung cancer: A review of standard treatment paradigms Article

DKN-01 in combination with tislelizumab and chemotherapy as a first-line therapy in unselected patients with advanced gastroesophageal adenocarcinoma (GEA): DisTinGuish trial Meeting Abstract

DNA Copy Numbers Profiles in Affinity-Purified Ovarian Clear Cell Carcinoma Article

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial Article

Dairy products and risk of hepatocellular carcinoma: The European Prospective Investigation into Cancer and Nutrition Article

Deficiencies in the CD40 and CD154 receptor-ligand system reduce experimental lung metastasis Article

Defining high-quality NSCLC care at US cancer centers. Meeting Abstract

Degree of Variability in Performance on Breast Cancer Quality Indicators: Findings From the Florida Initiative for Quality Cancer Care Article

Development and implementation of a breast cancer risk identification and reduction program in a large health care system Meeting Abstract

Development of an optimized conditionally replicative adenoviral agent for ovarian cancer Article

Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline Article

Dietary fat, fat subtypes and hepatocellular carcinoma in a large European cohort Article

Differential impact of EGFR exon 20 insertion location on tyrosine kinase inhibitor sensitivity Meeting Abstract

Diffuse Osteosclerosis-Associated Acute Myeloid Leukemia Article

Direct comparison of risk classification between MammaPrint (R), Oncotype DX (R) and MammoStrat (R) assays in patients with early stage breast cancer Meeting Abstract

Disparities between young and elderly patients in the first course of treatment for stage II and III rectal cancers. Meeting Abstract

Disparities in access to care among patients with appendiceal or colorectal cancer and peritoneal metastases: A medicare insurance-based study in the United States Article

Distributed network imaging and electrical impedance tomography of minimally invasive surgery Article

Disturbances in quality of life among BRCA mutation carriers. Meeting Abstract

Do Oncogenic Drivers Exist in Squamous Cell Carcinoma of the Lung? Article

Does more aggressive therapy improve outcomes in the treatment of unresectable stage III non-small cell lung cancer? Article

Does routine clinical assessment of older adults with gastroesophageal cancer tell the whole story? Meeting Abstract

Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable Stage IIIA/B nonsmall cell lung carcinoma - A modified Phase I/II trial Article

Dovitinib as second-line therapy in patients with fibroblast growth factor receptor 2 (FGFR2)-mutated or non-mutated advanced and/or metastatic endometrial cancer (EC): A single-arm, multicenter, phase II study. Meeting Abstract

Doxil and gemcitabine combination therapy for recurrent ovarian cancer: Results of a phase II trial. Meeting Abstract

Drug development in patients with advanced non-small cell lung cancer and poor performance status Review

Duration of first-line chemotherapy in advanced non-small-cell lung cancer: Less is more in the era of effective subsequent therapies Editorial Material

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC) Article

E3311 trial of transoral surgery for oropharynx cancer: Implementation of a novel surgeon credentialing and quality assurance process. Meeting Abstract

EGF receptor, Jaks and Stat3 crosstalk promote enhanced colony-forming, motility, migration, and invasive phenotype of cisplatin-resistant ovarian cancer cells Meeting Abstract

EGFR Genotyping of Matched Urine, Plasma , and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase Inhibitor Article

EJSO Journal

ESMO OPEN Journal

EUROPEAN JOURNAL OF CANCER Journal

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY Journal

EXPERIMENTAL HEMATOLGY & ONCOLOGY Journal

EXPERT REVIEW OF ANTICANCER THERAPY Journal

EXTRANEURAL METASTASES OF INFRATENTORIAL GLIOBLASTOMA-MULTIFORME TO THE PERITONEAL-CAVITY Article

Early Findings on Toxicity of Proton Beam Therapy With Concurrent Chemotherapy for Nonsmall Cell Lung Cancer Article

Effect of Early Nutrition Intervention on Advanced Nasopharyngeal Carcinoma Patients Receiving Chemoradiotherapy Article

Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy SWOG S1115 Study Randomized Clinical Trial Article

Effect of an equal-access military health system on racial disparities in colorectal cancer screening Article

Effect of early nutrition intervention on advanced nasopharyngeal carcinoma patients receiving chemoradiotherapy. Meeting Abstract

Effect of pelvic exenteration type and vaginal reconstruction on quality of life Meeting Abstract

Effect of response to last platinum-based chemotherapy in patients (pts) with platinum-sensitive, recurrent ovarian carcinoma in the phase III study ARIEL3 of rucaparib maintenance treatment Meeting Abstract

Effect of tolfenamic acid on ovarian cancer cell growth, targeting of specificity protein transcription factors, and expression of c-Met and survivin Meeting Abstract

Effects of plasma exosome isolation methods on detectable multiomic profiles in cancer patients and healthy controls Meeting Abstract

Effects of risk-reducing surgery on libido, self-image, and psychological status among BRCA mutation carriers. Meeting Abstract

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer Article

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non Small-Cell Lung Cancer Article

Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study Article

Efficacy and safety of poziotinib in treatment-naive HER2 exon 20 insertion (ex20ins) mutated non-small cell lung cancer (NSCLC): ZENITH20-4 Meeting Abstract

Efficacy and safety of poziotinib in treatment-naive NSCLC harboring HER2 exon 20 mutations: A multinational phase II study (ZENITH20-4) Meeting Abstract

Efficacy and safety of rucaparib maintenance treatment in patients from ARIEL3 with platinum-sensitive, recurrent ovarian carcinoma not associated with homologous recombination deficiency. Meeting Abstract

Efficacy and safety of selpercatinib in advanced RET-altered thyroid cancers: A meta-analysis and systematic review Meeting Abstract

Efficacy and safety of the ALK inhibitor alectinib in ALK plus non-small-cell lung cancer (NSCLC) patients who have failed prior crizotinib: An open-label, single-arm, global phase 2 study (NP28673). Meeting Abstract

Efficacy of the novel treatments of BCC with bone metastasis. Meeting Abstract

Eliminating Postoperative Radiation to the Pathologically Node-Negative Neck: Long-Term Results of a Prospective Phase II Study Article

Eliminating Radiotherapy to the Contralateral Retropharyngeal and High Level II Lymph Nodes in Head and Neck Squamous Cell Carcinoma Is Safe and Improves Quality of Life Article

Emerging Technologies in Prostate Cancer Radiation Therapy: Improving the Therapeutic Window Article

Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapy Review

Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer Article

Enhancement of antibody-dependent mechanisms of tumor cell lysis by a targeted activator of complement Article

Enhancing clinician confidence on the therapeutic management of non-small cell lung cancer (NSCLC) through continuing medical education (CME). Meeting Abstract

Enteral nutrition during the treatment of head and neck carcinoma - Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube? Article

EphrinB2 (B2) expression predicts poor response to PD1/L1 antibodies (Ab) in metastatic urothelial carcinoma (mUC). Meeting Abstract

Epidemiology of childhood diabetes. WoS Publication

Erectile dysfunction after robot-assisted radical prostatectomy Review

Erlotinib beyond progression study: Randomized phase II study comparing chemotherapy plus erlotinib with chemotherapy alone in EGFR TKI-responsive, advanced non-small cell lung cancer (NSCLC) that subsequently progresses. Meeting Abstract

Erlotinib beyond progression study: Randomized phase II study comparing chemotherapy plus erlotinib with chemotherapy alone in EGFR tyrosine kinase inhibitor (TKI)-responsive, non-small cell lung cancer (NSCLC) that subsequently progresses Meeting Abstract

Esophageal cancer in Hispanics: A propensity score matched analysis of the National Cancer Database. Meeting Abstract

Estrogen receptor positive breast cancer in an Afro-Caribbean cohort. Meeting Abstract

Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma - Pathologic and prognostic correlations Article

Ethnicity disparities of breast cancer in an insured population Meeting Abstract

Etirinotecan Pegol: Development of a Novel Conjugated Topoisomerase I Inhibitor Article

Evaluating the Quality of Colorectal Cancer Care in the State of Florida: Results From the Florida Initiative for Quality Cancer Care Article

Evaluation of rucaparib in platinum-sensitive recurrent ovarian carcinoma (rOC) in patients (pts) with or without residual bulky disease at baseline in the ARIEL3 study Meeting Abstract

Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs Review

Exploratory Subset Analysis of African Americans From the PointBreak Study: Pemetrexed-Carboplatin-Bevacizumab Followed by Maintenance Pemetrexed-Bevacizumab Versus Paclitaxel-Carboplatin-Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB/IV Nonsquamous Non-Small-Cell Lung Cancer Article

Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy Article

Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3 Meeting Abstract

Exploratory analysis of the effect of maintenance rucaparib on postprogression outcomes in patients (pts) with platinum-sensitive recurrent ovarian carcinoma (OC) and updated safety data from the phase 3 study ARIEL3. Meeting Abstract

Exploratory subgroup analysis of atezolizumab (atezo) clinical characteristics in patients (pts) with low circulating tumor DNA (ctDNA) in B-F1RST-a Phase II trial evaluating blood-based tumor mutational burden (bTMB) in NSCLC Meeting Abstract

Exploring Bias in Scientific Peer Review: An ASCO Initiative Review

Exploring molecular profiles of uterine carcinosarcoma with alterations in the chromatin remodeling pathway. Meeting Abstract

Exploring the role of pembrolizumab in mesothelioma: A single-arm analysis of available data Meeting Abstract

Expression profiles of a human pancreatic cancer cell line upon induction of apoptosis search for modulators in cancer therapy Article

Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy Article

Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma Article

F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma Article

FIRST-LINE CRIZOTINIB VS PEMETREXED plus CISPLATIN/CARBOPLATIN IN ASIAN PATIENTS WITH ADVANCED ALK plus NSCLC IN PROFILE 1014 Meeting Abstract

FIT-001: A phase 1 clinical trial of the farnesyl transferase inhibitor KO-2806 alone or as part of combination therapy for advanced solid tumors Meeting Abstract

FLORA-5: Front-line chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab [PCO] versus chemotherapy (Paclitaxel-Carboplatin-Placebo [PCP]) in patients with advanced epithelial ovarian cancer (EOC)-Phase III double-blind placebo controlled multinational study. Meeting Abstract

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis Review

FPGS expression to predict overall survival in non-small cell lung cancer patients treated with pemetrexed. Meeting Abstract

FREQUENT LOSS OF HETEROZYGOSITY FOR RB, TP53, AND CHROMOSOME ARM 3P, BUT NOT NME1 IN SQUAMOUS-CELL CARCINOMAS OF THE SUPRAGLOTTIC LARYNX Article

FRONTIERS IN ONCOLOGY Journal

Factors associated with extended survival for patients with platinum-resistant ovarian cancer treated with modified vaccinia oncolytic virotherapy. Meeting Abstract

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials Article

Feasibility of a telemedicine lifestyle-based rehabilitation program (HEAL) for gynecologic cancer patients. Meeting Abstract

Feasibility of functional evaluation in older adults with gastroesophageal cancer using fitness trackers. Meeting Abstract

Feasibility of using tumor-informed circulating tumor DNA (ctDNA)-based testing for patients with anal squamous cell carcinoma Meeting Abstract

Fibroblast Activation Protein-alpha-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade Article

Fibroblast growth factor receptor 3 (FGFR3) alterations in PROOF 302: A phase III trial of infigratinib (BGJ398) as adjuvant therapy in patients (pts) with invasive urothelial carcinoma (UC) Meeting Abstract

Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non-Small-Cell Lung Cancer Article

Final efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC) Meeting Abstract

Final efficacy results from IMpower132: First-line atezolizumab plus chemotherapy in patients with stage IV non-squamous NSCLC Meeting Abstract

Final survival follow-up and translational associations using interval indirect immunization with oregovomab (O) and poly ICLC in patients (pts) with recurrent platinum-resistant ovarian cancer (PROC). Meeting Abstract

First case of AML with rare chromosome translocations: a case report of twins Article

First comprehensive report of impact of genomic alterations, chemotherapy, targeted therapy and immunotherapy on outcomes in the genomics driven squamous master protocol LungMAP. Meeting Abstract

First-Line Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous KRAS Wild Type (WT) Non-Small-Cell Lung Cancer (NSCLC) Article

First-line carboplatin, pemetrexed, and panitumumab in patients with advanced nonsquamous KRAS wild type (WT) non-small cell lung cancer (NSCLC) Meeting Abstract

First-line crizotinib versus pemetrexed-cisplatin or pemetrexed-carboplatin in patients (pts) with advanced ALK-positive non-squamous non-small cell lung cancer (NSCLC): results of a phase III study (PROFILE 1014) Meeting Abstract

Forchlorfenuron-Induced Mitochondrial Respiration Inhibition and Metabolic Shifts in Endometrial Cancer Article

Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors Article

From Clinical Trials to Practice: Anticipating and Overcoming Challenges in Implementing Watch-and-Wait for Rectal Cancer Editorial Material

Fruit and vegetable consumption in relation to hepatocellular carcinoma in a multi-centre, European cohort study Article

Functional characterization of a fluorescent highly tumorigenic ovarian cancer line to test cellular therapy in experimental models Meeting Abstract

GEMSTONE-302: "If you keep doing the same thing you get the same result" Early Access

GYNECOLOGIC ONCOLOGY Journal

Gefitinib in Advanced Non-Small Cell Lung Cancer: Does It Deserve a Second Chance? Article

Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial Article

Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia Article

Gender disparities in hormone positive lung cancer. Meeting Abstract

Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts Review

Gene symbol: MEN1. Disease: Multiple endocrine neoplasia 1. WoS Publication

Genetic changes associated with telomerase activity in breast cancer Article

Genetic changes in breast cancer detected by comparative genomic hybridisation Article

Genomic analysis from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in patients with MIBC undergoing cystectomy. Meeting Abstract

Geriatric Oncology for the 21st Century: A Call for Action Editorial Material

Germline genetic testing of patients with penile carcinoma. Meeting Abstract

Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience Article

Guidance for clinicians and patients with non-small cell lung cancer in the time of precision medicine Review

HERPES-ZOSTER AND PROCARBAZINE THERAPY IN PATIENTS WITH MALIGNANT GLIOMA Article

HPV in HIV-infected women: implications for primary prevention Article

HSP90 Inhibitors in Lung Cancer: Promise Still Unfulfilled Article

Head and Neck Cancers Review

Head and Neck Cancers, Version 1.2015 Featured Updates to the NCCN Guidelines Article

Head and Neck Cancers, Version 2.2013 Featured Updates to the NCCN Guidelines Article

Head and Neck Cancers, Version 2.2014 Article

Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma Article

High activity of poziotinib in G778_P780dup HER2 exon 20 insertion mutations in non-small cell lung cancer (NSCLC) Meeting Abstract

Highlights in NSCLC From the 2014 ASCO Meeting Article

Histiocytic Sarcoma Arising From Clonally Related Mantle Cell Lymphoma Article

Histopathologic tumor response after induction chemotherapy and stereotactic body radiation therapy for borderline resectable pancreatic cancer Article

How I Treat Stage IV Non-Small Cell Lung Cancer in the Absence of Any Actionable Oncogenic Driver Editorial Material

Human Metapneumovirus Infection in Immunocompromised Patients Article

IMMUNOTOXINS - A CLINICAL REVIEW OF THEIR USE IN THE TREATMENT OF MALIGNANCIES Review

IMMUNOTOXINS IN THE THERAPY OF LEUKEMIAS AND LYMPHOMAS Article

IMpower130: Progression-free survival (PFS) and safety analysis from a randomised phase III study of carboplatin plus nab-paclitaxel (CnP) with or without atezolizumab (atezo) as first-line (1L) therapy in advanced non-squamous NSCLC Meeting Abstract

IMpower130: Progression-free survival (PFS) and safety analysis from a randomized phase 3 study of carboplatin plus nab-paclitaxel (CnP) with or without atezolizumab as first-line (1L) therapy in advanced non-squamous NSCLC Meeting Abstract

IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab plus carboplatin plus paclitaxel or nab-paclitaxel vs carboplatin plus nab-paclitaxel as 1L therapy in advanced squamous NSCLC. Meeting Abstract

IMpower131: Progression-free survival (PFS) and overall survival (OS) analysis of a randomised phase III study of atezolizumab plus carboplatin plus paclitaxel or nab-paclitaxel vs carboplatin plus nab-paclitaxel in 1L advanced squamous NSCLC Meeting Abstract

IMpower132: A phase III clinical program-1L atezolizumab plus platinum-based chemotherapy in chemo-naive advanced non-squamous NSCLC. Meeting Abstract

IMpower150: A post hoc analysis of efficacy outcomes in patients with KRAS, STK11 and KEAP1 mutations Meeting Abstract

IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations Meeting Abstract

IMpower150: Analysis of efficacy in patients (pts) with liver metastases (mets). Meeting Abstract

IMpower150: Clinical safety, tolerability and immune-related adverse events in a phase III study of atezolizumab (atezo) plus chemotherapy (chemo) +/- bevacizumab (bev) vs chemo + bev in 1L nonsquamous NSCLC Meeting Abstract

IMpower150: Efficacy of atezolizumab (atezo) plus bevacizumab (bev) and chemotherapy (chemo) in 1L metastatic nonsquamous NSCLC (mNSCLC) across key subgroups Meeting Abstract

IMpower150: Exploratory analysis of brain metastases development. Meeting Abstract

IMpower150: Updated efficacy analysis in patients with EGFR mutations Meeting Abstract

INDIAN JOURNAL OF CANCER Journal

INTEGRATIVE CANCER THERAPIES Journal

INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA MAY BE RESPONSIBLE FOR THE LYTIC MECHANISM DURING ANTITUMOR ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY Article

INTERNATIONAL JOURNAL OF CANCER Journal

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER Journal

INTERNATIONAL JOURNAL OF ONCOLOGY Journal

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Journal

INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY Journal

Identification of SNP-containing regulatory motifs in the myelodysplastic syndromes model using SNP arrays ad gene expression arrays Article

If Histology Matters ... Editorial Material

Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events Article

Immune-response markers and actual response to immune-oncology therapy in uterine serous carcinoma. Meeting Abstract

Immunotherapy in the Treatment of Platinum-Resistant Ovarian Cancer: Current Perspectives Review

Immunotherapy with intraperitoneal catumaxomab in patients with advanced ovarian cancer after a complete response to chemotherapy: A phase II study Meeting Abstract

Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors Article

Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer Article

Impact of exposure on outcomes with enfortumab vedotin in patients with locally advanced or metastatic urothelial cancer Meeting Abstract

Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer Article

Impact of next-generation sequencing (NGS) on treatment selection in acute myeloid leukemia (AML). Meeting Abstract

Improved Survival in Patients With Lymph Node-Positive Gastric Cancer Who Received Preoperative Radiation An Analysis of the Surveillance, Epidemiology, and End Results Database Article

Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions Review

Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC. WoS Publication

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer Article

Incorporating Bevacizumab and Erlotinib in the Combined-Modality Treatment of Stage III Non-Small-Cell Lung Cancer: Results of a Phase I/II Trial Article

Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the Clinic Review

Increased Survival Associated With Surgery and Radiation Therapy in Metastatic Gastric Cancer A Surveillance, Epidemiology, and End Results Database Analysis Article

Induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally-advanced esophageal and gastroesophageal junction cancer: A phase II study Meeting Abstract

Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: A dose-escalation phase I trial Article

Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma - A modified phase I trial Article

Infigratinib versus placebo in patients with resected urothelial cancer (UC) bearing FGFR3 mutation or fusion: Primary DFS analysis from the phase 3, randomized PROOF302 study. Meeting Abstract

Initial Evaluation of Quality Indicators for Psychosocial Care of Adults With Cancer Article

Initial breast cancer consult: Improving satisfaction and impact on distress. Meeting Abstract

Integrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction Article

Interim health related quality of life (QoL) from LAPACT, a Phase 2 trial of nab-paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC) Meeting Abstract

Interim phase 2 results of study CO-1686-008: A phase 1/2 study of the irreversible, mutant selective, EGFR inhibitor rociletinib (CO-1686) in patients with advanced non small cell lung cancer Meeting Abstract

Interprofessional care team practices and perspectives on immuno-oncology (IO) therapies for metastatic non-small cell lung cancer (mNSCLC): Insights from a nationwide survey. Meeting Abstract

Intracellular flow cytometric analysis of primary cultured breast tumor cells Article

Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014 Article

Intraoperative Radiotherapy for Breast Cancer: Its Perceived Simplicity Article

Investigational Agents in the Management of Non-Small Cell Lung Cancer Article

Irreversible electroporation: Implications for prostate ablation Article

Is there a genomic fingerprint of Radon (Rn)-induced lung cancer (LC)? Comparison of genomic alterations in LC specimens from high and low Rn zones. Meeting Abstract

Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes Review

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer Secondary Analyses of the ECOG 4599 and PointBreak Trials Article

Isolation and characterisation of vascular endothelial growth factor-165 specific scFv fragments by phage display Article

Isolation of human colorectal tumour reactive antibodies using phage display technology Article

JAMA ONCOLOGY Journal

JOURNAL OF CANCER Journal

JOURNAL OF CHEMOTHERAPY Journal

JOURNAL OF CLINICAL ONCOLOGY Journal

JOURNAL OF GASTROINTESTINAL ONCOLOGY Journal

JOURNAL OF GERIATRIC ONCOLOGY Journal

JOURNAL OF NEURO-ONCOLOGY Journal

JOURNAL OF ONCOLOGY PHARMACY PRACTICE Journal

JOURNAL OF ONCOLOGY PRACTICE Journal

JOURNAL OF PATHOLOGY Journal

JOURNAL OF SURGICAL ONCOLOGY Journal

JOURNAL OF THORACIC ONCOLOGY Journal

JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma Article

JQ1 suppresses tumor growth in tumorgraft models of pancreatic ductal adenocarcinoma Meeting Abstract

KRAS mutant epithelial ovarian carcinomas (EOC) represent distinct genomic genotypes Meeting Abstract

Karyotypic variation between independently cultured strains of the cell line MCF-7 identified by multicolour fluorescence in situ hybridization Article

Kinetics of postoperative serum vascular endothelial growth factor (VEGF) - Can it be used to predict curative resections in colorectal cancer? Article

LANCET ONCOLOGY Journal

LEUKEMIA & LYMPHOMA Journal

LUNG CANCER Journal

LUNG CANCER-TARGETS AND THERAPY Journal

Laparoscopy for rectal carcinoma: anterior resection. Review

Large rectal diverticulum in the setting of pelvic organ prolapse treated with robotic ventral mesh rectopexy: a case report Article

Large-cell neuroendocrine carcinoma of nasal cavity and paranasal sinuses after successful curative therapy: a case report and literature review Review

Lateral lymph node dissection and urogenital function with and without neoadjuvant treatment Editorial Material

Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study Article

Leukemic Non-nodal Mantle Cell Lymphoma: Diagnosis and Treatment Review

Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-naïve patients with pancreatic ductal adenocarcinoma Article

Lifestyle issues affecting health and well-being of BRCA mutation carriers. Meeting Abstract

Limited Resection for Early-Stage Lung Cancer Editorial Material

Limited-stage small-cell lung cancer: The current status of combined-modality therapy Review

Line-Enhanced Deformable Registration of Pulmonary Computed Tomography Images Before and After Radiation Therapy With Radiation-Induced Fibrosis Article

Literature on target therapy of malignant melanoma. Meeting Abstract

Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature Review

Localization Methods for Excisional Biopsy in Women With Nonpalpable Mammographic Abnormalities Article

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy Article

Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV plus ) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group. Meeting Abstract

Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma Article

Loss at Chromosome 13q22.2 Indicates Poor Survival in a Group of Grade 2 and Grade 3 Astrocytomas Meeting Abstract

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy Article

Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials Article

Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types Article

Lung cancer presenting with a solitary colon metastasis detected on positron emission tomography scan Article

M17-1A-MEDIATED, C17-1A-MEDIATED AND CSF25-MEDIATED ANTIBODY-DEPENDENT CELL-MEDIATED CYTOTOXICITY IN PATIENTS WITH ADVANCED CANCER Article

MDNA55: A locally administered IL4 guided toxin as a targeted treatment for recurrent glioblastoma. Meeting Abstract

MELANOMA RESEARCH Journal

MET Exnn 14 Skipping Mutations in Non-Small-Cell Lung Cancer: An Overview of Biology, Clinical Outcomes, and Testing Considerations Review

MINT I: Multi-Institutional Neo-adjuvant Therapy, MammaPrint Project I Meeting Abstract

MOLECULAR CANCER THERAPEUTICS Journal

MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib plus dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC). Meeting Abstract

Maintenance treatment with rucaparib for recurrent ovarian carcinoma in ARIEL3, a randomized phase 3 trial: The effects of best response to last platinum-based regimen and disease at baseline on efficacy and safety Article

Mammaprint and blueprint as prognostic indicators for elderly patients with early stage breast cancer Meeting Abstract

Management of Non-Small Cell Lung Cancer with Oligometastasis Article

Management of Normal Tissue Toxicity Associated With Chemoradiation (Primary Skin, Esophagus, and Lung) Review

Management of ovarian stromal cell tumors Review

Mark A. Socinski, MD, on Progression of Lung Cancer Treatment Editorial Material

Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane) Article

Mechanisms of buffer therapy resistance Article

Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study Article

Metabolic status of BRCA1 mutation carriers Meeting Abstract

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Therapy Article

Mismatch repair, p53 and chromosomal aberrations in primary colorectal carcinomas Article

Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic NSCLC (mNSCLC): Additional results from platinum-pretreated patients (pts) and EXCLAIM cohort of phase 1/2 study. Meeting Abstract

Mobocertinib (TAK-788) in metastatic EGFR Exon 20 Insertions (ex20ins) + NSCLC: Results of platinum-experienced Patients and the EXCLAIM Cohort of a Phase 1/2 Study Meeting Abstract

Modulation of protective T cell immunity by complement inhibitor expression on tumor cells Article

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial Article

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies Review

Molecular characterization of highly tumorigenic cell lines used in a xenograph model to investigate cellular therapy for the treatment of refractory ovarian cancer Meeting Abstract

Molecular determinants of response to immune-oncology therapy in uterine carcinosarcoma. Meeting Abstract

Molecular features of gliomas with high tumor mutational burden. Meeting Abstract

Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors - Part 4: p53 signaling pathway Review

Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors Part 5: Apoptosis and cell cycle Review

Motexafin gadolinium: a novel radiosensitizer for brain tumors Review

Mucosal Melanoma of the Head and Neck Review

Multi-Modality Therapy for Cancer of the Esophagus and GE Junction Article

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer Article

Multiple cell populations in colorectal carcinomas: Analysis by 3-colour fluorescence in situ hybridization Article

Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer Review

Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck Article

NEOADJUVANT TREATMENT OF STAGE IIIA NONSMALL CELL LUNG-CANCER - LONG-TERM RESULTS Article

NEURO-ONCOLOGY Journal

Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy Article

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer ABOUND.sqm): A Phase III Randomized Clinical Trial Article

Nationwide phase II randomized controlled trial of low-dose ibuprofen vs placebo for cancer-related cognitive impairment (CRCI) Meeting Abstract

Necitumumab plus Gemcitabine and Cisplatin as First-Line Therapy in Patients with Stage IV EGFR-Expressing Squamous Non-Small-Cell Lung Cancer German Subgroup Data from an Open-Label, Randomized Controlled Phase 3 Study (SQUIRE) Article

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial Article

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study Article

Neoadjuvant chemotherapy for breast cancer: Nodal downstaging is highly correlated with pathological complete response Meeting Abstract

Neoadjuvant or Adjuvant Therapy for Resectable Esophageal Cancer: Is There a Standard of Care? Article

Neural network analysis of tumor and germline profiling to predict survival of muscleinvasive bladder cancer following radical cystectomy: An analysis of the Cancer Genome Atlas (TCGA). Meeting Abstract

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial Article

Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review Review

Nonsurgical Options for Hepatocellular Carcinoma: Evolving Role of External Beam Radiotherapy Article

Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality Article

Novel CD43 specific phage antibodies react with early stage colorectal tumours Article

Novel Immunotherapeutic Approaches to Treating HPV-Related Head and Neck Cancer Review

Novel Treatment of Small-Cell Neuroendocrine of the Vagina Article

Novel agents in the treatment of lung cancer: Conference summary statement Editorial Material

Novel agents in the treatment of lung cancer: Fourth Cambridge conference Editorial Material

Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases Article

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC) Meeting Abstract

OCEANS: A randomized, double-blinded, placebo-controlled phase III trial of chemotherapy with or without bevacizumab (BEV) in patients with platinum-sensitive recurrent epithelial ovarian (EOC), primary peritoneal (PPC), or fallopian tube cancer (FTC). Meeting Abstract

ONCOGENE Journal

ONCOIMMUNOLOGY Journal

ONCOLOGIST Journal

ONCOLOGY Journal

ONCOLOGY LETTERS Journal

ONCOLOGY NURSING FORUM Journal

ONCOLOGY RESEARCH Journal

ONCOLOGY RESEARCH AND TREATMENT Journal

ONCOTARGETS AND THERAPY Journal

ORAL ONCOLOGY Journal

One-year follow-up results of a multi-center trial of intra-operative radiation therapy using electronic brachytherapy at the time of breast conservation surgery for early stage breast cancer Meeting Abstract

Open-label, phase II study of ladiratuzumab vedotin (LV) for unresectable locally advanced or metastatic solid tumors Meeting Abstract

Opportunities for cannabis in supportive care in cancer Review

Outcomes associated with robotic approach to pancreatic resections Article

Outcomes in patients with brain metastasis from esophageal carcinoma Article

Outcomes of Therasphere Radioembolization for Colorectal Metastases Article

Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis Article

Outpatient blinatumomab with digital monitoring in patients with measurable residual disease positive (MRD plus ) B-ALL in a phase 4 study. Meeting Abstract

Ovarian cancer: Current status and strategies for improving therapeutic outcomes Review

Overall survival (OS) analysis of IMpower150, a randomized Ph 3 study of atezolizumab (atezo) plus chemotherapy (chemo) +/- bevacizumab (bev) vs chemo + bev in 1L nonsquamous (NSQ) NSCLC. Meeting Abstract

Overall survival (OS) for first-line crizotinib versus chemotherapy in ALK plus lung cancer: Updated results from PROFILE 1014 Meeting Abstract

Overview of a chemoresponse assay in ovarian cancer Article

PACIFIC: A double-blind, placebo-controlled phase III study of durvalumab after chemoradiation therapy (CRT) in patients with stage III, locally advanced, unresectable NSCLC Meeting Abstract

PEDIATRIC BLOOD & CANCER Journal

PHASE (PH) I/II STUDY OF THE HISTONE DEACETYLASE INHIBITOR BELINOSTAT (BEL) IN COMBINATION WITH CARBOPLATIN (CA) AND PACLITAXEL (P) IN ADVANCED SOLID TUMORS (PH I) AND RELAPSED OVARIAN CANCER (PH II) Meeting Abstract

PIONEER: A phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2 Editorial Material

PRACTICAL RADIATION ONCOLOGY Journal

PRESERVE-003: Phase 3, two-stage, randomized study of ONC-392 versus docetaxel in metastatic non-small cell lung cancers that progressed on PD-1/PD-L1 inhibitors. Meeting Abstract

PRIMARY LYMPHOMA OF THE LIVER - 10 CASES AND A REVIEW OF THE LITERATURE Review

PROSTATE CANCER AND PROSTATIC DISEASES Journal

PROSTATE CRYOABLATION: A ROLE FOR THE RADIOLOGIST IN TREATING PROSTATE CANCER? Article

PSYCHO-ONCOLOGY Journal

Palliative care for patients with brain metastases Book Chapter

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subset Article

Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET plus colorectal carcinoma as a unique molecular subset of CRC Meeting Abstract

Pancreatic and bile duct cancer circulating tumor cells (CTC) form immune-resistant multi-cell type clusters in the portal venous circulation Article

Pancreatic cancer risk is modulated by inflammatory potential of diet and ABO genotype: a consortia-based evaluation and replication study Article

Pathologic response with neoadjuvant chemotherapy, immunotherapy, and chemoimmunotherapy for muscle-invasive bladder cancer (MIBC): A systematic review and meta-analysis. Meeting Abstract

Patient-Centered Outcomes in ARIEL3, a Phase III, Randomized, Placebo-Controlled Trial of Rucaparib Maintenance Treatment in Patients With Recurrent Ovarian Carcinoma Article

Patient-reported outcomes (PROs) in patients (pts) with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer (pA/rEC) in the ENGOT-EN6-NSGO/GOG3031/RUBY trial Meeting Abstract

Patient-reported outcomes (PROs) in the randomized, phase III IMpower150 study of atezolizumab (atezo) plus chemotherapy (chemo) +/- bevacizumab (bev) vs chemo + bev in 1L nonsquamous metastatic NSCLC (mNSCLC). Meeting Abstract

Patient-reported outcomes from the BESPOKE CRC study. Meeting Abstract

Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer Article

Patterns of Presentation and Failure in Patients With Gliomatosis Cerebri Treated With Partial-Brain Radiation Therapy Article

Patterns of change in cognitive function with anastrozole therapy Article

Pelvic sentinel lymph node status and risk of aortic nodal metastasis in patients with endometrial cancer. Meeting Abstract

Pembrolizumab (Pembro) with or without lenvatinib (Lenva) in first-line metastatic NSCLC with PD-L1 TPS >= 1% (LEAP-007): A phase III, randomized, double-blind study Meeting Abstract

Pemetrexed (Alimta) in small cell lung cancer Article

Penile Cancer Clinical Practice Guidelines in Oncology Article

Pentafecta Outcomes of 230 Cases of Robotic-assisted Radical Prostatectomy with Bilateral Neurovascular Bundle Preservation Article

Perioperative outcomes associated with robotic Ivor Lewis esophagectomy in patient's undergoing neoadjuvant chemoradiotherapy Article

Peritoneal Flap Following Lymph Node Dissection in Robotic Radical Prostatectomy: A Novel "Bunching" Technique Article

Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation Article

Personalized Medicine in Non-Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor-Targeted Therapy? Article

Phase (Ph) 1/2a study of CLN-081 in patients (pts) with NSCLC with EGFR exon 20 insertion mutations (Ins20). Meeting Abstract

Phase 1 study (DRAGON) of SRK-181 (linavonkibart), a latent TGFβ1 inhibitor, combined with pembrolizumab in patients with anti-PD1 resistant advanced solid tumors: Updated results of expansion part Meeting Abstract

Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer Article

Phase 1/2 Study of Rilotumumab (AMG 102), a Hepatocyte Growth Factor Inhibitor, and Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer Article

Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease Article

Phase 1/2 study of pepinemab, an inhibitor of semaphorin 4D, in combination with pembrolizumab as first-line treatment of recurrent or metastatic head and neck cancer (KEYNOTE-B84). Meeting Abstract

Phase 1b results from OP-1250-001, a dose escalation and dose expansion study of OP-1250, an oral CERAN, in subjects with advanced and/or metastatic estrogen receptor (ER)-positive, HER2-negative breast cancer (NCT04505826) Meeting Abstract

Phase 1b study of oncolytic vaccinia virus GL-ONC1 in recurrent ovarian cancer (ROC). Meeting Abstract

Phase 2 pilot trial of RRx-001 as an anti-mucositis agent in patients with head and neck cancer treated with chemoradiation (PREVLAR). Meeting Abstract

Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancer Article

Phase 3 randomised study of canfosfamide (Telcyta (R), TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer Article

Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma Article

Phase I Trial of Carboplatin and Etoposide in Combination with Panobinostat in Patients with Lung Cancer Article

Phase I trial of consensus interferon in patients with metastatic renal cell carcinoma: Toxicity and immunological effects Article

Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma Article

Phase I trial of phenoxodiol delivered by continuous intravenous infusion in patients with solid cancer Article

Phase I trial of the combination of irinotecan, paclitaxel, and carboplatin in patients with advanced non-small-cell lung cancer Article

Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies Article

Phase I/II study of ipilimumab plus nivolumab (IPI-NIVO) combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma. Meeting Abstract

Phase I/II study of ipilimumab plus nivolumab combined with sacituzumab govitecan in patients with metastatic cisplatin-ineligible urothelial carcinoma. Meeting Abstract

Phase I/II study of mobocertinib in EGFR exon 20 insertion (ex20ins) + metastatic NSCLC (mNSCLC): Updated results from platinum-pretreated patients (PPP) Meeting Abstract

Phase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant Glioma Article

Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Harbor a Sensitizing EGFR Mutation or Have Never Smoked Article

Phase II Study of Amrubicin As Second-Line Therapy in Patients With Platinum-Refractory Small-Cell Lung Cancer Article

Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2(+) Breast Cancer Article

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib Article

Phase II clinical trial of atezolizumab (A) in advanced non-small cell lung cancer (NSCLC) patients (pts) previously treated with PD1-directed therapy Meeting Abstract

Phase II clinical trial of novel agent PBI-05204 in patients with metastatic pancreatic adenocarcinoma (mPDA) Meeting Abstract

Phase II clinical trial of the epothilone B analog, ixabepilone, in patients with non-small-cell lung cancer whose tumors have failed first-line platinum-based chemotherapy Article

Phase II evaluation of dalantercept, a soluble recombinant activin receptor-like kinase 1 (ALK1) receptor-fusion protein, for treatment of recurrent/persistent endometrial cancer: GOG-0229N. Meeting Abstract

Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with relapsed ovarian cancer Meeting Abstract

Phase II multicenter trial of the histone deactylase inhibitor (HDACi) belinostat, carboplatin and paclitaxel (BelCaP) in patients (pts) with relapsed epithelial ovarian cancer (EOC) Meeting Abstract

Phase II study of FOLFOXIRI plus panitumumab (pmab) followed by evaluation for resection, in patients (pts) with metastatic KRAS wild-type colorectal cancer (mCRC) with liver metastases only. Meeting Abstract

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer Article

Phase II study of gemcitabine in patients with metastatic breast cancer Meeting Abstract

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma Article

Phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin-bound paclitaxel (nab paclitaxel) and carboplatin in HER2+locally advanced breast cancer Meeting Abstract

Phase II trial of eribulin in patients who do not achieve pathologic complete response (pCR) following neoadjuvant chemotherapy Article

Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated stage IIIB/IV nonsmall cell lung carcinoma Article

Phase II trial of lurbinectedin combined with avelumab as maintenance therapy for metastatic urothelial carcinoma with stable or responding disease following platinumbased chemotherapy. Meeting Abstract

Phase II trial of oncolytic vaccinia virus primed immunochemotherapy in platinum-resistant/refractory ovarian cancer (PRROC) (NCT02759588) Meeting Abstract

Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash Meeting Abstract

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer Article

Phase II/III study of SM-88 in patients with metastatic pancreatic cancer Meeting Abstract

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer Article

Phase III confirmatory efficacy and safety study of proposed bevacizumab biosimilar (MYL-1402O) compared with avastin, in the first-line treatment of patients with stage IV non-squamous non-small cell lung cancer (nsNSCLC) Meeting Abstract

Phase III double-blind study comparing the efficacy and safety of proposed biosimilar MYL-1402O and reference bevacizumab in stage IV non-small-cell lung cancer Article

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394 Article

Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer Article

Phase Ib Study of Bavituximab With Carboplatin and Pemetrexed in Chemotherapy-Naive Advanced Nonsquamous None-Small-Cell Lung Cancer Article

Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR2/3 genetic alterations (GAs). Meeting Abstract

Pilot study of a passive non-radioactive electromagnetic wave technology to localize non-palpable breast lesions Meeting Abstract

Pilot study of subcutaneous amifostine in patients undergoing postoperative intensity modulated radiation therapy for head and neck cancer: Preliminary data Article

Plasma cell leukemia - one in a million: A case report Article

Plasma methionine, choline, betaine, and dimethylglycine in relation to colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Article

Pleomorphic Lobular Carcinoma in Situ: Treatment Options for a New Pathologic Entity Article

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer Article

Pooled Analysis of CNS Response to Alectinib in Two Studies of Pretreated Patients With ALK-Positive Non-Small-Cell Lung Cancer Article

Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies Article

Pooled analyses of immune-related adverse events (irAEs) and efficacy from the phase 3 trials IMpower130, IMpower132, and IMpower150. Meeting Abstract

Poor Compliance With Adjuvant Chemotherapy Use Associated With Poorer Survival in Patients With Rectal Cancer: An NCDB Analysis Article

Population pharmacokinetics (Pop PK) of MYL-1402O (a proposed biosimilar to bevacizumab) and reference product (Avastin) in patients with nonsquamous non-small cell lung cancer (nsNSCLC). Meeting Abstract

Poziotinib activity and durability of responses in previously treated EGFR exon 20 NSCLC patients - a Phase 2 study Meeting Abstract

Poziotinib administered twice daily improves safety and tolerability in patients with EGFR or HER2 exon 20 mutant NSCLC(ZENITH20-5). Meeting Abstract

Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial Article

Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients. Meeting Abstract

Practice Patterns for Organ Preservation in US Patients With Rectal Cancer, 2006-2020 Article

Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations Article

Pre-diagnostic copper and zinc biomarkers and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort Article

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer Article

Precautions in the use of intensity-modulated radiation therapy Article

Precision Medicine to Treat Urothelial Carcinoma-The Way Forward Review

Prediagnostic Plasma Bile Acid Levels and Colon Cancer Risk: A Prospective Study Article

Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma Article

Predicting length of survival for adult, outpatient oncology patients using clinic visit data Meeting Abstract

Predicting the need for palliative thoracic radiation after first-line chemotherapy for advanced nonsmall cell lung carcinoma Article

Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial F-18-FDG PET/CT Article

Prediction of risk factors associated with readmission after robotic esophagectomy. Meeting Abstract

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer Review

Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy Article

Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer Database Article

Predictors of acute throat or esophageal patient reported pain during radiation therapy for head and neck cancer Article

Predictors of mortality following cardiac surgery for carcinoid heart disease. Meeting Abstract

Predictors of outcome for pemetrexed (Pem) in metastatic NSCLC (mNSCLC). Meeting Abstract

Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer Article

Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias - A retrospective review Article

Prevention and Management of Complications During Robotic-assisted Laparoscopic Radical Prostatectomy Following Comprehensive Planning: A Large Series Involving a Single Surgeon Article

Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy - Comparison of ondansetron, prochlorperazine, and dexamethasone Article

Primary Bladder Preservation Treatment for Urothelial Bladder Cancer Article

Primary PFS and safety analyses of a randomized Phase III study of carboplatin plus paclitaxel plus /- bevacizumab, with or without atezolizumab in 1L non-squamous metastatic NSCLC (IMpower150) Meeting Abstract

Primary PFS and safety analyses of a randomized phase III study of carboplatin plus paclitaxel plus /- bevacizumab, with or without atezolizumab in 1L non-squamous metastatic nsclc (IMPOWER150) Meeting Abstract

Primary efficacy results from B-F1RST, a prospective phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC) Meeting Abstract

Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer Article

ProApoliploprotein A1 - A serum marker of brain metastases in lung cancer patient Article

Profiling of tRNA Halves and YRNA Fragments in Serum and Tissue From Oral Squamous Cell Carcinoma Patients Identify Key Role of 5 ' tRNA-Val-CAC-2-1 Half Article

Prognostic Value of KRAS Mutation Subtypes and PD-L1 Expression in Patients With Lung Adenocarcinoma Article

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma Article

Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy Article

Prognostic value of circulating tumor DNA (ctDNA) testing in patients (pts) with rectal cancer after neoadjuvant therapy (NAT) and surgery. Meeting Abstract

Prospective clinical evaluation of blood-based tumor mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC): Interim B-F1RST results. Meeting Abstract

Prostate derived Ets factor (PDEF), an emerging biomarker in cancer Meeting Abstract

Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappa B-independent mechanisms Article

Protocol optimization of a targeted sequencing panel for genomic profiling of bronchoalveolar lavage fluid in lung cancer Article

Quality of Care in Non-Small-Cell Lung Cancer: Findings From 11 Oncology Practices in Florida Article

Quality of Life With Brachytherapy for Low-Risk Localized Prostate Cancer Article

Quality of Life With External Beam Radiation Therapy Article

Quality of life (QoL) outcomes in patients (pts) with zanidatamab (zani)-treated HER2-positive (HER2+) biliary tract cancer (BTC) in the phase IIb HERIZON-BTC-01 study Meeting Abstract

Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery Article

RADIANCE: An open-label, nonrandomized, prospective biomarker study to assess analytic concordance between noninvasive testing and tissue testing for EGFR T790M mutation detection in patients with non-small cell lung cancer Meeting Abstract

RADIOTHERAPY AND ONCOLOGY Journal

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY Journal

Racial disparity in the TP53 mutation spectra in triple-negative breast cancers: Validation with TCGA data Meeting Abstract

Radiation Therapy and Esophageal Cancer Article

Radiation Therapy for Rectal Cancer: Current Status and Future Directions Article

Radiation-induced sarcoma after high-dose thoracic radiation therapy in non-small-cell lung cancer Article

Radiation-induced skin reactions: mechanism and treatment Review

Raising the level of cancer care: Feasibility and reported benefit of a virtual tumor board. Meeting Abstract

Randomized Phase II Study of Bevacizumab in Combination With Chemotherapy in Previously Untreated Extensive-Stage Small-Cell Lung Cancer: Results From the SALUTE Trial Article

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial Article

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer Article

Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer Article

Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer Article

Randomized phase II trial of docetaxel/irinotecan and gemcitabine/irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer Article

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic Conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105 Article

Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer Article

Randomized phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small cell lung cancer (NSCLC) Meeting Abstract

Randomized phase III study of canfosfamide (C, TLK286) plus pegylated liposomal doxorubicin (PLD) versus PLD as second-line therapy in platinum (P) refractory or resistant ovarian cancer (OC) Meeting Abstract

Randomized phase III trial comparing cisplatin-etoposide to carhoplatin-paclitaxel in advanced or metastatic non-small cell lung cancer Article

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer Article

Re-Evaluating Duration of Therapy in Advanced Non-Small-Cell Lung Cancer: Is It Really Duration or Is It More About Timing and Exposure? Editorial Material

ReNeu: A pivotal phase 2b trial of mirdametinib in children and adults with neurofibromatosis type 1 (NF1)-associated symptomatic inoperable plexiform neurofibroma (PN). Meeting Abstract

Real-WorldTreatment Patterns andProgression-FreeSurvival Associated with Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Inhibitor Therapies forALK plus Non-SmallCell Lung Cancer Article

Real-world progression-free survival of patients on anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) for ALK plus non-small cell lung cancer (NSCLC) Meeting Abstract

Recent progress in the use of monoclonal antibodies for imaging and therapy. Review

Receptor Channel TRPC6 Is a Key Mediator of Notch-Driven Glioblastoma Growth and Invasiveness Article

Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study Article

Recurrence and survival after robotic-assisted radical hysterectomy (RRH) for early-stage cervical cancer (CC): Experience may matter. Meeting Abstract

Recurrence rates in cervical cancer patients treated with abdominal versus minimally invasive radical hysterectomy: A multi-institutional analysis of 700 cases. Meeting Abstract

Reducing preventable ED visits in patients with advanced NSCLC: Collective insights from three cancer centers. Meeting Abstract

Reduction of metastasis using a non-volatile buffer Article

Regional Multiteam Systems in Cancer Care Delivery Article

Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial Meeting Abstract

Relevance of Sp1 and survivin expression in epithelial ovarian cancer patients and their usefulness as potential therapeutic targets Meeting Abstract

Response to Letter to the Editor. Letter

Results from a first-in-human phase 1B study of a complement factor H inhibitor (GT103) in patients with non-small cell lung cancer (NSCLC) Meeting Abstract

Results from the pivotal phase (Ph) 2b HERIZON-BTC-01 study: Zanidatamab in previously-treated HER2-amplified biliary tract cancer (BTC) Meeting Abstract

Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non-Small Cell Lung Cancer Article

Results of a Single Institution Experience with Dose-Escalated Chemoradiation for Locally Advanced Unresectable Non-Small Cell Lung Cancer Article

Results of a multicenter pilot study of weekly nab-paclitaxel, carboplatin with bevacizumab, and trastuzumab as neoadjuvant therapy in HER2+locally advanced breast cancer with SPARC correlatives Meeting Abstract

Results of a quality improvement program to increase complete lung cancer biomarker testing rates by focusing on system, physician, and other factors associated with adverse health outcomes. Meeting Abstract

Resveratrol-induced apoptotic death in human U251 glioma cells Article

Retrospective Study of Venous Thromboembolic and Intracerebral Hemorrhagic Events in Glioblastoma Patients Article

Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial Article

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial Article

Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia Article

Robotic-assisted laparoscopic radical prostatectomy: a report of the current state Review

Robotics in Advanced Gastrointestinal Surgery The Bariatric Experience Review

Role of human papillomavirus in laryngeal squamous cell carcinoma: A meta-analysis of cohort study Article

Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial Article

S100 beta as a predictor of brain metastases - Brain versus cerebrovascular damage Article

SDF-1 alpha stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II Article

SGNLVA-002: Single arm, open label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of patients with unresectable locally-advanced or metastatic triple-negative breast cancer Meeting Abstract

SGNLVA-002: Single arm, open-label, phase Ib/II study of ladiratuzumab vedotin (LV) in combination with pembrolizumab for first-line treatment of triple-negative breast cancer Meeting Abstract

SUPPORTIVE CARE IN CANCER Journal

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA Journal

SURGICAL ONCOLOGY-OXFORD Journal

Sacituzumab govitecan (SG) plus enfortumab vedotin (EV) for metastatic urothelial carcinoma (mUC) treatment-experienced (DAD) and with pembrolizumab (P) in treatment naive UC (DAD-IO) Meeting Abstract

Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma Article

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium Article

Safety and Chemopreventive Effect of Polyphenon E in Preventing Early and Metastatic Progression of Prostate Cancer in TRAMP Mice Article

Safety and Efficacy of Neratinib in Combination with Capecitabine in Patients with ErbB2-Positive Breast Cancer Meeting Abstract

Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non-Small-Cell Lung Cancer Article

Safety and activity of CLN-081 (TAS6417) in NSCLC with EGFR Exon 20 insertion mutations (Ins20). Meeting Abstract

Safety and clinical activity results from a phase Ib study of alectinib plus atezolizumab in ALK plus advanced NSCLC (aNSCLC). Meeting Abstract

Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer Article

Safety and efficacy of immune checkpoint inhibitors (ICI) in advanced penile squamous cell carcinoma (PeCa): An international study from the Global Society of Rare Genitourinary Tumors (GSRGT). Meeting Abstract

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors Article

Safety and efficacy of time restricted eating (TRE) in improving response to immunotherapy in patients with head and neck cancer (HNSCC). Meeting Abstract

Safety and efficacy profile of belzutifan, a hypoxia-inducible factor-2α inhibitor, in patients with renal cell carcinoma: Meta-analysis and systematic review Meeting Abstract

Safety and feasibility of salvage robot-assisted radical prostatectomy for recurrent prostate cancer Meeting Abstract

Safety and feasibility of salvage robot-assisted radical prostatectomy for recurrent prostate cancer. Meeting Abstract

Safety and tolerance of multiple weekly intracavitary injections of 1311-chlorotoxin (TM-601): Preliminary results of a prospective clinical trial in patients with recurrent glioblastorna multiforme. Meeting Abstract

Safety data from a phase II study of neoadjuvant bevacizumab and trastuzumab administered with albumin bound paclitaxel (nab paclitaxel) and carboplatin in HER2+locally advanced breast cancer Meeting Abstract

Safety of Bevacizumab in Patients With Non-Small-Cell Lung Cancer and Brain Metastases Article

Safety of Neratinib (HKI-272) in Combination with Capecitabine in Patients with Solid Tumors: A Phase 1/2 Study Meeting Abstract

Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions Article

Safety, tolerability and preliminary efficacy of poziotinib with twice daily strategy in EGFR/HER2 Exon 20 mutant non-small cell lung cancer Meeting Abstract

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: Report of a phase II trial Article

Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study Article

Second-line, low-dose, weekly paclitaxel in patients with Stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel Article

Selection and Outcomes in Abdominoperineal Resection Review

Selenium status is associated with colorectal cancer risk in the European prospective investigation of cancer and nutrition cohort Article

Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3 sigma and survivin Article

Serum vascular endothelial growth factor in breast cancer: Its relation with cancer type and estrogen receptor status Article

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma Article

Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer Review

Small business technology transfer (STTR) phase I study (1 R41 MD006148-01) of an automated voice response (AVR) system to improve symptom management in neuro-oncology patients Meeting Abstract

Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients Article

Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis Article

Spinal cord tumors: review of etiology, diagnosis, and multidisciplinary approach to treatment. Review

Squamous cell carcinoma of the nasopharynx metastasising to rectum: First case report and literature review Article

Standardized Titration Protocol Reduces the Incidence of Paclitaxel Infusion-Related Hypersensitivity Reactions Article

Stereotactic Body Radiotherapy in Patients With Stage I Non-Small-Cell Lung Cancer Aged 75 Years and Older: Retrospective Results From a Multicenter Consortium Article

Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3 Meeting Abstract

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma Article

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma Article

Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer Database Article

Surgery for PatientsWith Rectal Cancer-Time to Listen to the Patients and Recognize Reality Editorial Material

Surgery versus SABR for NSCLC Letter

Surgical therapy of genitourinary cancers Editorial Material

Survival analysis comparing neoadjuvant chemoradiotherapy versus perioperative chemotherapy for locoregional gastric cancer Meeting Abstract

Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer Article

Systemic Therapy for Advanced Appendiceal Adenocarcinoma: An Analysis From the NCCN Oncology Outcomes Database for Colorectal Cancer Article

TARGETED THERAPIES Biomarkers in NSCLC for selecting cetuximab therapy Editorial Material

TECHNOLOGY IN CANCER RESEARCH & TREATMENT Journal

THE SAFETY OF NERATINIB (HKI-272) IN COMBINATION WITH CAPECITABINE IN PATIENTS WITH SOLID TUMORS: A PHASE 1/2 STUDY Meeting Abstract

THYROID-DYSFUNCTION CAN PREDICT RESPONSE TO IMMUNOTHERAPY WITH INTERLEUKIN-2 AND INTERFERON-2-ALPHA Article

TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib plus pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)-Results from ROC cohort. Meeting Abstract

TOTAL GASTRECTOMY FOR ADVANCED CANCER - A WORTHWHILE PALLIATIVE PROCEDURE Article

TRANSLATIONAL LUNG CANCER RESEARCH Journal

TURCOTS-SYNDROME - FLOW CYTOMETRIC ANALYSIS Article

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib Review

Targeting Sp1 and survivin for potential ovarian cancer therapy: Comparative assessment of anti-cancer NSAID tolfenamic acid and cisplatin Meeting Abstract

Targeting lysophospholipid metabolism inhibits pancreatic cancer cell proliferation under nutrient-limiting conditions Meeting Abstract

Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal Article

Targeting the BDNF/TrkB pathway for the treatment of tumors Review

Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease Article

Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer Article

Tea and coffee consumption and risk of esophageal cancer: The European prospective investigation into cancer and nutrition study Article

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial Article

Temporal dependence of the effect of radiation on erlotinib-induced skin rash Letter

The Applicability of the Results in the Asian Population of ORIENT-11 to a Western Population According to the ICH-E5 Framework Article

The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement Article

The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan plus enfortumab vedotin for metastatic urothelial carcinoma Article

The Emerging Role of Biomarkers in Advanced Non-Small-Cell Lung Cancer Review

The Florida Pancreas Collaborative Next-Generation Biobank: Infrastructure to Reduce Disparities and Improve Survival for a Diverse Cohort of Patients with Pancreatic Cancer Article

The HSP90 Inhibitor Ganetespib Radiosensitizes Human Lung Adenocarcinoma Cells Article

The Impact of Body Mass Index on Esophageal Cancer Article

The Many Controversies of Stage IIIA/IIIB Lung Cancer The Balmanoukian/Ettinger article reviewed Editorial Material

The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update Article

The Role of Consolidation Treatment in Locally Advanced Unresectable NSCLC Article

The Role of Postoperative Chemoradiation for Oropharyngeal Carcinoma: A Critical Appraisal Revisited Letter

The Spruce clinical trial: Double-blind randomized phase II trial of carboplatin and pemetrexed plus /- apatorsen in patients with previously untreated stage IV non-squamous non-small-cell lung cancer. Meeting Abstract

The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis Editorial Material

The association of ERCC1 and clinical outcomes of women with advanced ovarian cancer Meeting Abstract

The current status of adjuvant chemotherapy for resected non-small cell lung cancer Review

The effect of pentoxifylline on spontaneous and experimental metastasis of the mouse Neuro2a neuroblastoma Article

The emergence of a unique population in non-small cell lung cancer: Systemic or loco-regional relapse following postoperative adjuvant platinum-based chemotherapy Review

The evolving role of pemetrexed (Alimta) in lung cancer Article

The impact of COVID-19 infection on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors Meeting Abstract

The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors Meeting Abstract

The impact of age on complications, survival, and cause of death following colon cancer surgery Article

The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel Article

The impact of therapeutic mediastinal radiation on stent healing in cancer patients: An optical coherence tomography study. Meeting Abstract

The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma Article

The prognostic value of KRAS mutation subtypes and PD-L1 expression in patients with lung adenocarcinoma. Meeting Abstract

The role of bevacizumab in recurrent, platinum-sensitive ovarian cancer Review

The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal of the published literature and National Comprehensive Cancer Network guidelines Review

The safety and efficacy of immune checkpoint inhibitor rechallenge after immune-related adverse events in stage IV NSCLC patients. Meeting Abstract

The significance of enlarged cervical lymph nodes in diagnosing thyroid cancer Article

The social and behavioral influences (SBI) study: study design and rationale for studying the effects of race and activation on cancer pain management Article

Therapeutic Prospects of Abemaciclib for Patients with Endometrial Cancer Review

Therapeutic advances in local-regional therapy for stage III non-small-cell lung cancer: Evolving role of dose-escalated conformal (3-dimensional) radiation therapy Review

Three-Dimensional Prostate Mapping Biopsy Has a Potentially Significant Impact on Prostate Cancer Management Article

Thymic Neoplasms: a Clinical Update Article

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib Article

Timing of adverse events during maintenance treatment with rucaparib for recurrent ovarian cancer in the phase III ARIEL3 study Meeting Abstract

Tissue factor-dependent and-independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study Article

Tolerability, Efficacy, and Safety of Pegylated Liposomal Doxorubicin in Combination with Carboplatin Versus Gemcitabine-Carboplatin for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer: A Systematic Review Review

Tongue swelling as a manifestation of tongue metastasis from pulmonary sarcomatoid carcinoma: A case report Article

Toward an Integrated Knowledge Environment to Support Modern Oncology Review

Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer Article

Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study Article

Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer A Phase 1/2 Open-label Nonrandomized Clinical Trial Article

Treatment Rationale and Study Design for the PointBreak Study: A Randomized, Open-label Phase III Study of Pemetrexed/Carboplatin/Bevacizumab Followed by Maintenance Pemetrexed/Bevacizumab Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients with Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer Article

Treatment of Surgically Resectable Non-Small-Cell Lung Cancer in Elderly Patients Review

Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2 Article

Trends in local therapy utilization and survival of patients with de-novo metastatic prostate cancer treated by hormone therapy with or without systemic therapy intensification with chemotherapy. Meeting Abstract

Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150 Article

Tumor burden (TB) and treatment exposure (TE) in patients (pts) with malignant pleural mesothelioma (MPM) receiving nintedanib (N)/placebo (P) in combination with first-line pemetrexed/cisplatin (PEM/CIS) in phase II of the LUME-Meso study. Meeting Abstract

Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma Meeting Abstract

Tumor-informed assessment of circulating tumor DNA and its incorporation into practice for patients with hepatobiliary cancers. Meeting Abstract

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS Journal

Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression Article

Unlocking precision oncology with FGFR inhibition in urothelial carcinoma Editorial Material

Unusual presentation of a neuroendocrine tumor in the ileostomy specimen after rectal cancer treatment: case report Article

Unveiling the influence of SGLT2 inhibitors on clinical outcomes in patients with cancer with therapy-related cardiac dysfunction: A meta-analysis and systemic review Meeting Abstract

Update on taxanes in the first-line treatment of advanced non-small-cell lung cancer Review

Updated efficacy and safety results from a global phase 2, open-label, single-arm study (NP28673) of alectinib in crizotinib-refractory ALK plus non-small-cell lung cancer (NSCLC) Meeting Abstract

Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in patients with advanced renal cell carcinoma (aRCC) in the CLEAR study Meeting Abstract

Updated efficacy of lenvatinib (LEN) plus pembrolizumab (PEMBRO) vs sunitinib (SUN) in patients (pts) with advanced renal cell carcinoma (aRCC) in the CLEAR study Meeting Abstract

Updated results from a phase I/II study of mobocertinib (TAK788) in NSCLC with EGFR exon 20 insertions (exon20ins) Meeting Abstract

Updated results of induction FOLFOX prior to CROSS chemoradiotherapy and surgery in patients with locally advanced esophageal and gastroesophageal junction cancer: A phase II study Meeting Abstract

Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection Article

Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care Article

Use of pegylated liposomal doxorubicin in the management of platinum-sensitive recurrent ovarian cancer: current concepts Review

Use of thalidomide as consolidation therapy in ovarian and primary peritoneal cancers. Meeting Abstract

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma Article

Using intensity-modulated radiotherapy to spare the kidney in a patient with seminoma and a solitary kidney: a case report. WoS Publication

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Article

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma Article

Variation in outcomes across surgeons meeting the Leapfrog volume standard for complex oncologic surgery Article

Vascular endothelial growth factor in premenopausal women - indicator of the best time for breast cancer surgery? Article

Venetoclax combined with hypomethylating agents for favorable risk acute myeloid leukemia: A single center experience Meeting Abstract

WORLD JOURNAL OF CLINICAL ONCOLOGY Journal

Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial Article

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Diabetes Article

Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment Article

What constitutes high-quality NSCLC care? Overarching quality considerations for improving NSCLC care at US cancer centers. Meeting Abstract

YAP/TAZ: a promising target for squamous cell carcinoma treatment Review

ZENITH20, a multinational, multi-cohort phase II study of poziotinib in NSCLC patients with EGFR or HER2 exon 20 insertion mutations Meeting Abstract

Zanidatamab (zani) in previously treated HER2+biliary tract cancer (BTC): Impact on patient-reported pain outcomes in the phase 2b HERIZON-BTC-01 study Meeting Abstract

Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study Article

Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study Meeting Abstract

nab-Paclitaxel (nab-P) plus gemcitabine (G) for patients (Pts) with locally advanced pancreatic cancer (LAPC): Interim efficacy and safety results from the Phase 2 LAPACT Trial Meeting Abstract

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis Article

nab-paclitaxel plus carboplatin induction followed by nab-paclitaxel maintenance in squamous non-small cell lung cancer (NSCLC): Results from the ABOUND. sqm study Meeting Abstract

nab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy Article

ONCOLOGY Web of Science Category

Research

category

Other

broader concept

Explore

Institutes